Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Pennsylvania, United States.
Department of Pathology, Yale University, Connecticut, United States.
Elife. 2018 Oct 25;7:e37925. doi: 10.7554/eLife.37925.
Whereas inactivation is a primary event in clear cell renal cell carcinoma (ccRCC), the precise mechanism(s) of how this interacts with the secondary mutations in tumor suppressor genes, including , /, , and/or , remains unclear. Gene expression analyses reveal that VHL, PBRM1, or KDM5C share a common regulation of interferon response expression signature. Loss of HIF2α, PBRM1, or KDM5C in cells reduces the expression of interferon stimulated gene factor 3 (ISGF3), a transcription factor that regulates the interferon signature. Moreover, loss of SETD2 or BAP1 also reduces the ISGF3 level. Finally, ISGF3 is strongly tumor-suppressive in a xenograft model as its loss significantly enhances tumor growth. Conversely, reactivation of ISGF3 retards tumor growth by PBRM1-deficient ccRCC cells. Thus after inactivation, HIF induces ISGF3, which is reversed by the loss of secondary tumor suppressors, suggesting that this is a key negative feedback loop in ccRCC.
虽然失活是透明细胞肾细胞癌 (ccRCC) 的主要事件,但它与肿瘤抑制基因中的二次突变(包括 、 、 和/或 )相互作用的确切机制尚不清楚。基因表达分析表明,VHL、PBRM1 或 KDM5C 共同调控干扰素反应表达特征。细胞中 HIF2α、PBRM1 或 KDM5C 的缺失会降低干扰素刺激基因因子 3 (ISGF3) 的表达,ISGF3 是一种调节干扰素特征的转录因子。此外,SETD2 或 BAP1 的缺失也会降低 ISGF3 水平。最后,ISGF3 在异种移植模型中具有强烈的肿瘤抑制作用,因为其缺失显著增强了肿瘤生长。相反,ISGF3 的重新激活会通过 PBRM1 缺陷型 ccRCC 细胞来减缓肿瘤生长。因此,在 失活后,HIF 诱导 ISGF3,而二次肿瘤抑制因子的缺失会逆转这种情况,这表明这是 ccRCC 中的一个关键负反馈回路。